Literature DB >> 23085052

Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach.

Jesse D Sammon1, Pierre I Karakiewicz, Maxine Sun, Shyam Sukumar, Praful Ravi, Khurshid R Ghani, Marco Bianchi, James O Peabody, Shahrokh F Shariat, Paul Perrotte, Jim C Hu, Mani Menon, Quoc-Dien Trinh.   

Abstract

PURPOSE: The use of robot-assisted radical prostatectomy has increased rapidly despite the absence of randomized, controlled trials showing the superiority of this approach. While recent studies suggest an advantage for perioperative complication rates, they fail to account for the volume-outcome relationship. We compared perioperative outcomes after robot-assisted and open radical prostatectomy, while considering the impact of this established relationship.
MATERIALS AND METHODS: Using the NIS (Nationwide Inpatient Sample), we abstracted data on patients treated with radical prostatectomy in 2009. Univariable and multivariable logistic regression analyses were done to compare the rates of blood transfusion, intraoperative and postoperative complications, prolonged length of stay, increased hospital charges and mortality between robot-assisted and open radical prostatectomy overall and across volume quartiles.
RESULTS: An estimated 77,616 men underwent radical prostatectomy, including a robot-assisted and an open procedure in 63.9% and 36.1%, respectively. Low volume centers averaged 26.2 robot-assisted and 5.2 open cases, while very high volume centers averaged 578.8 robot-assisted and 150.2 open cases. Overall, patients treated with the robot-assisted procedure experienced a lower rate of adverse outcomes than those treated with the open procedure for all measured categories. Across equivalent volume quartiles robot-assisted radical prostatectomy outcomes were generally favorable. However, the open procedure at high volume centers resulted in a lower postoperative complication rate (OR 0.59, 95% CI 0.46-0.75), elevated hospital charges (OR 0.75, 95% CI 0.64-0.87) and a comparable blood transfusion rate (OR 1.38, 95% CI 0.93-2.02) relative to the robot-assisted procedure at low volume centers.
CONCLUSIONS: Regionalization has occurred to a greater extent for robot-assisted than for open radical prostatectomy with an associated benefit in overall outcomes. Nonetheless, low volume institutions experienced inferior outcomes relative to the highest volume centers irrespective of approach. These findings demonstrate the importance of accounting for hospital volume when examining the benefit of a surgical technique.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23085052     DOI: 10.1016/j.juro.2012.10.028

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

1.  Analysis of the pentafecta learning curve for laparoscopic radical prostatectomy.

Authors:  D W Good; G D Stewart; J U Stolzenburg; S A McNeill
Journal:  World J Urol       Date:  2013-12-11       Impact factor: 4.226

Review 2.  A systematic review of the volume-outcome relationship for radical prostatectomy.

Authors:  Quoc-Dien Trinh; Anders Bjartell; Stephen J Freedland; Brent K Hollenbeck; Jim C Hu; Shahrokh F Shariat; Maxine Sun; Andrew J Vickers
Journal:  Eur Urol       Date:  2013-04-19       Impact factor: 20.096

3.  Comparison of open and robotic-assisted prostatectomy: The University of British Columbia experience.

Authors:  Louis-Olivier Gagnon; S Larry Goldenberg; Kenny Lynch; Antonio Hurtado; Martin E Gleave
Journal:  Can Urol Assoc J       Date:  2014-03       Impact factor: 1.862

4.  Robot-assisted versus laparoscopic nephroureterectomy for upper-tract urothelial cancer: A population-based assessment of costs and perioperative outcomes.

Authors:  Vincent Trudeau; Giorgio Gandaglia; Jonas Shiffmann; Ioana Popa; Shahrokh F Shariat; Francesco Montorsi; Paul Perrotte; Quoc-Dien Trinh; Pierre I Karakiewicz; Maxine Sun
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

Review 5.  Robot-Assisted Radical Prostatectomy vs. Open Retropubic Radical Prostatectomy for Prostate Cancer: A Systematic Review and Meta-analysis.

Authors:  Xiu-Wu Pan; Xin-Ming Cui; Jing-Fei Teng; Dong-Xu Zhang; Zhi-Jun Wang; Fa-Jun Qu; Yi Gao; Xin-Gang Cui; Dan-Feng Xu
Journal:  Indian J Surg       Date:  2014-09-24       Impact factor: 0.656

Review 6.  Prostatic surgery associated acute kidney injury.

Authors:  Elerson Carlos Costalonga; Verônica Torres Costa E Silva; Renato Caires; James Hung; Luis Yu; Emmanuel A Burdmann
Journal:  World J Nephrol       Date:  2014-11-06

Review 7.  Robotic Surgical System for Radical Prostatectomy: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2017-07-07

8.  Prospective Multicenter Comparison of Open and Robotic Radical Prostatectomy: The PROST-QA/RP2 Consortium.

Authors:  Peter Chang; Andrew A Wagner; Meredith M Regan; Joseph A Smith; Christopher S Saigal; Mark S Litwin; Jim C Hu; Matthew R Cooperberg; Peter R Carroll; Eric A Klein; Adam S Kibel; Gerald L Andriole; Misop Han; Alan W Partin; David P Wood; Catrina M Crociani; Thomas K Greenfield; Dattatraya Patil; Larry A Hembroff; Kyle Davis; Linda Stork; Daniel E Spratt; John T Wei; Martin G Sanda
Journal:  J Urol       Date:  2021-08-26       Impact factor: 7.450

9.  Postoperative mortality 90 days after robot-assisted laparoscopic prostatectomy and retropubic radical prostatectomy: a nationwide population-based study.

Authors:  Johan Björklund; Yasin Folkvaljon; Alexander Cole; Stefan Carlsson; David Robinson; Stacy Loeb; Pär Stattin; Olof Akre
Journal:  BJU Int       Date:  2016-02-15       Impact factor: 5.588

10.  Robotic prostatectomy is associated with increased patient travel and treatment delay.

Authors:  Matthew J Maurice; Hui Zhu; Simon P Kim; Robert Abouassaly
Journal:  Can Urol Assoc J       Date:  2016 May-Jun       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.